Home/RaeSedo/Jan Mark Creidenberg

JM

Jan Mark Creidenberg

CEO

Therapeutic Areas

Asthma Respiratory Diseases

RaeSedo Pipeline

Drug	Indication	Phase
SP-A Peptide Therapeutic	Asthma (broad-spectrum, with focus on severe/eosinophilic phenotypes)	Pre-clinical

Leadership Team at RaeSedo

Julie Ledford, PhD

Co-Founder / Scientific Lead

Monica Kraft, MD

Co-Founder / Clinical Advisor

Jody Yarbrough, MBA

View full RaeSedo profile